Barclays’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,700
| Closed | -$1K | – | 4202 |
|
|
2016
Q3 | $1K | Buy |
1,700
+1,685
| +11,233% | +$991 | ﹤0.01% | 3900 |
|
|
2016
Q2 | $0 | Sell |
15
-395
| -96% | – | ﹤0.01% | 4144 |
|
|
2016
Q1 | $0 | Buy |
410
+395
| +2,633% | – | ﹤0.01% | 3983 |
|
|
2015
Q4 | $0 | Sell |
15
-830
| -98% | – | ﹤0.01% | 4300 |
|
|
2015
Q3 | $1K | Sell |
845
-2,253
| -73% | -$2.67K | ﹤0.01% | 3918 |
|
|
2015
Q2 | $3K | Sell |
3,098
-872
| -22% | -$844 | ﹤0.01% | 3880 |
|
|
2015
Q1 | $4K | Sell |
3,970
-5,616
| -59% | -$5.66K | ﹤0.01% | 3808 |
|
|
2014
Q4 | $10K | Sell |
9,586
-9,851
| -51% | -$10.3K | ﹤0.01% | 3772 |
|
|
2014
Q3 | $38K | Sell |
19,437
-7,444
| -28% | -$14.6K | ﹤0.01% | 3135 |
|
|
2014
Q2 | $81K | Sell |
26,881
-22,617
| -46% | -$68.2K | ﹤0.01% | 2825 |
|
|
2014
Q1 | $99K | Sell |
49,498
-1,294
| -3% | -$2.59K | ﹤0.01% | 2798 |
|
|
2013
Q4 | $203K | Buy |
50,792
+32,216
| +173% | +$129K | ﹤0.01% | 2631 |
|
|
2013
Q3 | $38K | Buy |
18,576
+14,195
| +324% | +$29K | ﹤0.01% | 3300 |
|
|
2013
Q2 | $10K | Buy |
+4,381
| New | +$10K | ﹤0.01% | 3916 |
|